dizzy sometimes; felt weakness; felt "asthmatic"; had a difficult time walking a straight line,had to use walker; , highly dependent on the walker; difficult time with urination control, urinated in the bed last night, urination problem; feels like COVID-19 infection; feels like Frankenstein; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (felt weakness), ASTHMA (felt "asthmatic"), GAIT DISTURBANCE (had a difficult time walking a straight line,had to use walker), WALKING AID USER (, highly dependent on the walker) and URINARY INCONTINENCE (difficult time with urination control, urinated in the bed last night, urination problem) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049L21A, 059H21A, 024M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Patient had not tested nor Diagnosed with Covid  No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: Flu shot (Allergies: Became severely ill in the 1970's after a flu shot) in 1970. Past adverse reactions to the above products included Illness with Flu shot. Concurrent medical conditions included Kidney stones (Start Date: 5 to 6 years ago) and Enlarged prostate (Start Date: years ago).   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 14-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 16-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 16-May-2022, the patient experienced ASTHENIA (felt weakness), ASTHMA (felt "asthmatic"), GAIT DISTURBANCE (had a difficult time walking a straight line,had to use walker), WALKING AID USER (, highly dependent on the walker), URINARY INCONTINENCE (difficult time with urination control, urinated in the bed last night, urination problem), SUSPECTED COVID-19 (feels like COVID-19 infection) and FEELING ABNORMAL (feels like Frankenstein). On an unknown date, the patient experienced DIZZINESS (dizzy sometimes). At the time of the report, ASTHENIA (felt weakness) and GAIT DISTURBANCE (had a difficult time walking a straight line,had to use walker) was resolving, ASTHMA (felt "asthmatic"), WALKING AID USER (, highly dependent on the walker), SUSPECTED COVID-19 (feels like COVID-19 infection) and FEELING ABNORMAL outcome was unknown and URINARY INCONTINENCE (difficult time with urination control, urinated in the bed last night, urination problem) and DIZZINESS (dizzy sometimes) had not resolved.            The patient reported that he sees a kidney doctor. Patient reported Height: 5'10" - mentioned he is "shrinking.  Concomitant drugs included Unknown enlarged prostate medication.    Treatment details were not given.     Company Comment -This is a spontaneous case concerning an 86-year-old male with no relevant medical history reported, who experienced the unexpected non-serious AESI event of suspected Covid-19. Patient had not tested nor diagnosed with Covid. The event occurred on the same day of the fourth dose of mRNA-1273 vaccine on 16-May-2022. The patient experienced asthenia had a gait disturbance and was feeling abnormal. The patient had received first dose of mRNA-1273 on 22-Jan-2021, second dose on 19-Feb-2021 and third dose on 14-Jan-2022. The event outcome was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning an 86-year-old male with no relevant medical history reported, who experienced the unexpected non-serious AESI event of suspected Covid-19. Patient had not tested nor diagnosed with Covid. The event occurred on the same day of the fourth dose of mRNA-1273 vaccine on 16-May-2022. The patient experienced asthenia had a gait disturbance and was feeling abnormal. The patient had received first dose of mRNA-1273 on 22-Jan-2021, second dose on 19-Feb-2021 and third dose on 14-Jan-2022. The event outcome was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.